Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Paul Niziolek"'
Autor:
Sonia Afshariyamchlou, Michelle Ng, Asmaa Ferdjallah, Stuart J. Warden, Paul Niziolek, Imranul Alam, Lynda E. Polgreen, Erik A. Imel, Paul Orchard, Michael J. Econs
Publikováno v:
JBMR Plus, Vol 6, Iss 6, Pp n/a-n/a (2022)
ABSTRACT The osteopetroses are a group of rare genetic diseases caused by osteoclast dysfunction or absence. The hallmark of osteopetrosis is generalized increased bone mineral density (BMD). However, the bone is fragile and fractures are common. Aut
Externí odkaz:
https://doaj.org/article/a41863ed5ec24e759ee6d33c2abd7568
Autor:
Tori Kroon, Neharika Bhadouria, Paul Niziolek, Daniel Edwards, Roy Choi, Erica L Clinkenbeard, Alexander Robling, Nilsson Holguin
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 37(6)
Intervertebral disc (IVD) degeneration is a leading cause of low back pain, characterized by accelerated extracellular matrix breakdown and IVD height loss, but there is no approved pharmacological therapeutic. Deletion of Wnt ligand competitor Lrp5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::130037898c6a3a4099bc78b7825ef135
https://pubmed.ncbi.nlm.nih.gov/35278242
https://pubmed.ncbi.nlm.nih.gov/35278242
Autor:
null Tori Kroon, null Neharika Bhadouria, null Paul Niziolek, null Daniel Edwards, null Erica L Clinkenbeard, null Alexander Robling, null Nilsson Holguin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::662c55ca4f8aaebab92cf6184e04b276
https://doi.org/10.1002/jbmr.4546/v3/response1
https://doi.org/10.1002/jbmr.4546/v3/response1
Autor:
null Sonia Afshariyamchlou, null Michelle Ng, null Asmaa Ferdjallah, null Stuart J. Warden, null Paul Niziolek, null Imranul Alam, null Lynda E. Polgreen, null Erik A. Imel, null Paul Orchard, null Michael J. Econs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9318808a4609775384533b551d336682
https://doi.org/10.1002/jbm4.10616/v3/response1
https://doi.org/10.1002/jbm4.10616/v3/response1
Autor:
Lauren Dickerson, Korbin Davis, Jason Childress, Taylor Stethen, Paul Niziolek, Mark Tann, Sarah Spargo, Pauline Kim, Lawrence D Wurtz, Christopher Collier, Anna Roshal, Daniel A. Rushing, Samantha Ann Armstrong
Publikováno v:
Journal of Clinical Oncology. 40:e23524-e23524
e23524 Background: Patients (pts) with locally advanced or metastatic sarcoma have limited treatment options and a poor prognosis, with PFS of < 6mos and OS of < 15mos. A phase 2 trial showed encouraging response with combination ipilimumab and nivol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::056238ea79bd30ac9fa7b7f6b100a01c
https://doi.org/10.1200/jco.2022.40.16_suppl.e23524
https://doi.org/10.1200/jco.2022.40.16_suppl.e23524